Skip to main content
×
×
Home
  • Access
  • Open access
  • Cited by 1
  • Cited by
    This (lowercase (translateProductType product.productType)) has been cited by the following publications. This list is generated based on data provided by CrossRef.

    Benkler, Yochai 2017. Law, Innovation, and Collaboration in Networked Economy and Society. Annual Review of Law and Social Science, Vol. 13, Issue. 1, p. 231.

    ×
  • Print publication year: 2017
  • Online publication date: October 2017

2 - Leviathan in the Commons: Biomedical Data and the State

Recommend this book

Email your librarian or administrator to recommend adding this book to your organisation's collection.

Governing Medical Knowledge Commons
  • Online ISBN: 9781316544587
  • Book DOI: https://doi.org/10.1017/9781316544587
Please enter your name
Please enter a valid email address
Who would you like to send this to *
×
Ankeny, Rachel A. and Leonelli, Sabina, Valuing Data in Postgenomic Biology: How Data Donation and Curation Practices Challenge the Scientific Publication System, in Postgenomics: Perspectives on Biology after the Genome 126 (Richardson, Sarah S. and Stevens, Hallam eds., Duke University Press 2015).
Benkler, Yochai, Review: Commons and Growth: The Essential Role of Open Commons in Market Economies, 80 U. Chicago L. Rev. 1499 (2013).
Benson, Dennis, Lipman, David J., and Ostell, Jams, GenBank, 21 Nucleic Acids Research 2963 (1993).
Bermuda Principles, Summary of Principles Agreed at the First International Strategy Meeting on Human Genome Sequencing (1996), www.ornl.gov/sci/techresources/Human_Genome/research/bermuda.shtml
Boyle, James, The Second Enclosure Movement and the Construction of the Public Domain, 66 Law & Contemp. Probs. (2003).
Bozeman, Barry, Technology Transfer and Public Policy: A Review of Research and Theory, 29 Research Policy 627 (2000).
ClinicalTrials.gov, Overview of FDAAA and Other Trial Registration (2012), https://prsinfo.clinicaltrials.gov/trainTrainer/Overview-FDAAA-Other-Regist-Policies.pdf
ClinicalTrials.gov, Trends, Charts, and Maps (2015), https://clinicaltrials.gov/ct2/resources/trends
Contreras, Jorge L., Constructing the Genome Commons in Governing Knowledge Commons 99 (Frischmann, Brett M., Madison, Michael J., and Strandburg, Katherine J. eds., Oxford University Press 2014).
Contreras, Jorge L., Bermuda’s Legacy: Policy, Patents, and the Design of the Genome Commons, 12 Minn. J.L. Sci. & Tech. 61 (2011).
Contreras, Jorge L. and Reichman, Jerome H., Sharing by Design: Data and Decentralized Commons, 350 Science 1312 (2015).
Cook-Deegan, Robert, The Gene Wars – Science, Politics, and the Human Genome (Norton 1994).
Couzin-Frankel, Jennifer, Trust Me, I’m a Medical Researcher, 347 Science 501 (2015).
Demaine, Linda J. and Fellmeth, Aaron Xavier, Reinventing the Double Helix. A Novel and Nonobvious Reconceptualization of the Biotechnology Patent, 55 Stanford Law Review 303 (2002).
Demsetz, Harold, Toward a Theory of Property Rights, 57 Am. Econ. Rev. 347 (1967).
Ehrenfeld, David W., Conserving Life on Earth (Oxford University Press 1972).
Exec. Off. President, Big Data: Seizing Opportunities, Preserving Values (2014).
Food and Drug Administration Amendments Act of 2007 (FDAAA).
Fndn. for the Natl. Inst. Health (FNIH), How We Work (2015), http://fnih.org/about/how-we-work.
Frischmann, Brett M., Infrastructure: The Social Value of Shared Resources (Oxford University Press 2012).
Frischmann, Brett M., Two Enduring Lessons from Elinor Ostrom, 9 J. Institutional Econ. 387 (2013).
Galison, Peter, The Many Faces of Big Science in Big Science: The Growth of Large-Scale Research 1 (Galison, Peter and Hevly, Bruce eds., Stanford University Press 1992).
The GAIN Collaborative Research Group (GAIN), New Models of Collaboration in Genome-Wide Association Studies: The Genetic Association Information Network, 39 Nature Genetics 1045 (2007).
Hardin, Garrett, The Tragedy of the Commons, 162 Science 1243 (1968).
Heller, Michael A. and Eisenberg, Rebecca S., Can Patents Deter Innovation? The Anticommons in Biomedical Research, 280 Science 698 (1998).
Hess, Charlotte and Ostrom, Elinor, Introduction: An Overview of the Knowledge Commons in Understanding Knowledge as a Commons: From Theory to Practice 4 (Hess, Charlotte and Ostrom, Elinor eds., MIT Press 2007).
Hilgartner, Stephen, Biomolecular Databases – New Communication Regimes for Biology? 17 Science Communication 240 (1995).
Holden, Arthur, The SNP Consortium: Summary of a Private Consortium Effort to Develop an Applied Map of the Human Genome, 32 BioTechniques 2226 (2002).
Holden, Arthur L. et al., The International Serious Adverse Events Consortium, 13 Nat. Rev. Drug Discovery 795 (2014).
Holdren, John P., Director, Off. Sci. Tech. Policy, Memorandum for the Heads of Executive Departments and Agencies: Increasing Access to the Results of Federally Funded Scientific Research (2013).
Holdren, John P., The 2017 Budget: Investing in American Innovation (2016), www.whitehouse.gov/sites/default/files/microsites/ostp/fy_17_ostp_slide_deck.pdf
Hudson, Kathy L. and Collins, Francis S., Sharing and Reporting the Results of Clinical Trials, 313 J. Am. Med. Assn. 355 (2014).
Inst. of Med. (IOM) and National Research Council, Large-Scale Biomedical Science (National Research Council 2003).
Inst. of Med. (IOM), Sharing Clinical Trial Data: Maximizing Benefits, Minimizing Risk (National Research Council 2015).
Int’l HapMap Consortium, The International HapMap Project, 426 Nature 789 (2003).
Kaiser, Jocelyn, Celera to End Subscriptions and Give Data to Public GenBank, 308 Science 775 (2005).
Kaiser, Jocelyn, Funding for Key Data Resources in Jeopardy, 351 Science 14 (2016).
Loiter, Jeffrey M. and Norberg-Bohm, Vicky, Technology Policy and Renewable Energy: Public Roles in the Development of New Energy Technologies, 37 Energy Policy 85 (1999).
Madison, Michael J., Knowledge Curation, 86 Notre Dame L. Rev. 1957 (2011).
Madison, Michael J., Frischmann, Brett M., and Strandburg, Katherine J., Constructing Commons in the Cultural Environment, 95 Cornell L. Rev. 657 (2010).
Mazzucato, Mariana, The Entrepreneurial State: Debunking Public vs. Private Sector Myths (Public Affairs 2013).
Mcelheny, Victor K., Drawing the Map of Life – Inside the Human Genome Project (Basic Books 2010).
Mishra, A., Schofield, P. N., and Bubela, T. M., Sustaining Large-Scale Infrastructure to Promote Pre-Competitive Biomedical Research: Lessons from Mouse Genomics, 33 New Biotechnology 280 (2016).
Nat’l. Acad. Sci., Eng. and Med. (NAS), Assessment of the Usefulness and Availability of NASA’s Earth and Space Science Mission Data (2002), http://sites.nationalacademies.org/cs/groups/ssbsite/documents/webpage/ssb_051716.pdf.
Nat’l. Center for Advancing Translational Sciences (NCATS), Alliances at NCATS (2015), https://ncats.nih.gov/alliances/about.
Nat’l Center for Biotechnology Info. (NCBI), The NCBI Handbook (2nd ed.) (2013).
Nat’l Human Genome Research Inst. (NHGRI), NHGRI Policy Regarding Intellectual Property of Human Genomic Sequence (1996), www.genome.gov/10000926.
Nat’l. Inst. Health (NIH), Genomic Data Sharing (GDS) – Categories, Statistics, and Summary Information on Policy Violations (2015), https://gds.nih.gov/20ComplianceStatistics_dbGap.html.
Nat’l. Inst. Health (NIH), NIH Public-Private Partnership Program – Partnership Examples (2010), http://ppp.od.nih.gov/pppinfo/examples.asp.
Nat’l Inst. Health (NIH), Budget (2017), https://www.nih.gov/about-nih/what-we-do/budget
Nat’l Library Medicine (NLM), Congressional Justification FY 2016, www.nlm.nih.gov/about/2016CJ.html#Justification.
Nat’l. Research Council (NRC), Rising to the Challenge: US Innovation Policy for the Global Economy (National Research Council 2014).
Nat’l. Research Council (NRC), Reaping the Benefits of Genomic and Proteomic Research (National Research Council: 2006), www.nap.edu/catalog/798/infrastructure-for-the-21st-century-framework-for-a-research-agenda
OECD, Data-Driven Innovation: Big Data for Growth and Well-Being (OECD Publishing 2015).
Ostrom, Elinor, Governing the Commons: The Evolution of Institutions for Collective Action (Cambridge University Press 1990).
Ostrom, Elinor, Understanding Institutional Diversity (Princeton University Press 2005).
Paltoo, Dina N. et al., Data Use under the NIH GWAS Data Sharing Policy and Future Directions, 46 Nature Genetics 934 (2014).
Rai, Arti Kaur, Regulating Scientific Research: Intellectual Property Rights and the Norms of Science, 94 Northwestern U. L. Rev. 77 (1999).
Rai, Arti K. and Eisenberg, Rebecca S., Bayh-Dole Reform and the Progress of Biomedicine, 66 Law & Contemp. Probs. 289 (2003).
Reichman, Jerome H., Uhlir, Paul F., and Dedeurwaerdere, Tom, Governing Digitally Integrated Genetic Resources, Data, and Literature: Globally Intellectual Property Strategies for a Redesigned Microbial Research Commons (Cambridge University Press 2016).
Catherine, Rhodes, Governance of Genetic Resources: A Guide to Navigating the Complex Global Landscape (Edward Elgar 2013).
Rose, Carol M., The Comedy of the Commons: Commerce, Custom, and Inherently Public Property, 53 U. Chicago L. Rev. 711 (1986).
Saito, Hiroki and Gill, Christopher J., How Frequently Do the Results from Completed US Clinical Trials Enter the Public Domain? A Statistical Analysis of the Clinicaltrials.Gov Database, 9 PLoS One (2014).
Sarnoff, Joshua D., Government Choices in Innovation Funding (With Reference to Climate Change), 62 Emory L. Rev. 1087 (2013).
Scotchmer, Suzanne, Innovation and Incentives (MIT Press 2004).
Shreeve, James, The Genome War (Knopf 2004).
Smith, Robert J., Resolving the Tragedy of the Commons by Creating Private Property Rights in Wildlife, 1 CATO J. 439 (1981).
Strandburg, Katherine J., Frischmann, Brett M., and Cui, Can, The Rare Diseases Clinical Research Network and the Urea Cycle Disorders Consortium as Nested Knowledge Commons, in Governing Knowledge Commons 155 (Frischmann, Brett M., Madison, Michael J., and Strandburg, Katherine J. eds., Oxford University Press 2014).
Strasser, Bruno J., GenBank – Natural History in the 21st Century? 322 Science 537 (2008).
US Food & Drug Admin., Critical Path Initiative (2017), http://www.fda.gov/ScienceResearch/SpecialTopics/CriticalPathInitiative/.
US Food and Drug Admin., FDA News Release: FDA and International Serious Adverse Events Consortium Complete Third Data Release (2010), www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm201286.htm.
US Patent and Trademark Office, Revised Utility Examination Guidelines; Request for Comments, 64 Fed. Reg. 71440 (1999).
US Securities and Exchange Comm., Report to the Congress on Section 107 of the National Securities Markets Improvement Act of 1996 – Privatization of EDGAR (1997), https://www.sec.gov/news/studies/edgpriv.htm.
Vertinsky, Liza S., Patents, Partnerships, and the Pre-Competitive Collaboration Myth in Pharmaceutical Innovation, 48 U.C. Davis L. Rev. 101 (2015).
White House, Exec. Order 13642, Making Open and Machine Readable the New Default for Government Information (2013).